These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone). Cox D; O'Kennedy R; Thornes RD Hum Toxicol; 1989 Nov; 8(6):501-6. PubMed ID: 2591993 [TBL] [Abstract][Full Text] [Related]
4. Lympidem (a coumarin derivative) induced reversible hepatotoxicity in an adult Sri Lankan. Satarasinghe RL; Jayawardana MA Drug Metabol Drug Interact; 2009; 24(1):89-94. PubMed ID: 19354003 [TBL] [Abstract][Full Text] [Related]
5. CYP2A6 polymorphisms: is there a role for pharmacogenomics in preventing coumarin-induced hepatotoxicity in lymphedema patients? Farinola N; Piller NB Pharmacogenomics; 2007 Feb; 8(2):151-8. PubMed ID: 17286538 [TBL] [Abstract][Full Text] [Related]
6. Troxerutin protects the isolated perfused rat liver from a possible lipid peroxidation by coumarin. Adam BS; Pentz R; Siegers CP; Strubelt O; Tegtmeier M Phytomedicine; 2005 Jan; 12(1-2):52-61. PubMed ID: 15693708 [TBL] [Abstract][Full Text] [Related]
8. Toxic hepatitis due to benzo-pyrone. Faurschou P Hum Toxicol; 1982 Mar; 1(2):149-50. PubMed ID: 7173895 [No Abstract] [Full Text] [Related]
9. Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer. Burgos A; Alcaide A; Alcoba C; Azcona JM; Garrido J; Lorente C; Moreno E; Murillo E; Olsina-Pavia J; Olsina-Kissler J; Samaniego E; Serra M Lymphology; 1999 Mar; 32(1):3-10. PubMed ID: 10197321 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics: its role in re-establishing coumarin as treatment for lymphedema. Farinola N; Piller N Lymphat Res Biol; 2005; 3(2):81-6. PubMed ID: 16000056 [TBL] [Abstract][Full Text] [Related]
11. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. Loprinzi CL; Kugler JW; Sloan JA; Rooke TW; Quella SK; Novotny P; Mowat RB; Michalak JC; Stella PJ; Levitt R; Tschetter LK; Windschitl H N Engl J Med; 1999 Feb; 340(5):346-50. PubMed ID: 9929524 [TBL] [Abstract][Full Text] [Related]
12. Drug-associated asymptomatic elevations of transaminase in drug safety assessments. Jick H Pharmacotherapy; 1995; 15(1):23-5. PubMed ID: 7739941 [No Abstract] [Full Text] [Related]
13. Alanine aminotransferase (GPT) in rainbow trout: plasma enzyme levels as an index of liver damage. Pfeifer KF; Weber LJ; Larson RE Proc West Pharmacol Soc; 1977; 20():431-7. PubMed ID: 896851 [No Abstract] [Full Text] [Related]
14. [A case of liver damage following coumarin medication]. Kreiter H; Fink U Med Klin; 1967 Jan; 62(1):12-5. PubMed ID: 6032217 [No Abstract] [Full Text] [Related]
15. [Serum transaminases and mental manifestations in alcoholic liver disease]. Olivieri G; Tinelli G; Mancuso CE Fracastoro; 1971; 64(3):176-8. PubMed ID: 5143151 [No Abstract] [Full Text] [Related]
16. [Glutamate dehydrogenase activity in the blood serum in viral hepatitis and other liver diseases]. Braginskiĭ DM; Aleksandrovskaia RA; Paktoris EA; Sinaĭko GA; Ketiladze ES Sov Med; 1974 Oct; (10):103-7. PubMed ID: 4428228 [No Abstract] [Full Text] [Related]
18. [Liver-protecting and alanine aminotransferase lowering actions of hongning gantai]. Chen Y; Li M; Xie T; Li W; Zhou J; He X Zhongguo Zhong Yao Za Zhi; 1995 May; 20(5):299-300, 312, 320, inside cover. PubMed ID: 7492364 [TBL] [Abstract][Full Text] [Related]